Volume 4,Issue 2
Objective: To investigate the clinical efficacy of intense pulsed light combined with doxycycline in the treatment of rosacea. Methods: A sample of 60 patients with rosacea admitted to our hospital from January 2021 to December 2023 were selected and grouped into the observation group (n = 30) and the control group (n = 30) by using the randomized numerical table sampling method. The patients in the control group were treated with doxycycline, and the patients in the observation group were treated with intense pulsed light combined with doxycycline. The clinical effective rate and recurrence rate, clinical symptom score, skin barrier function indexes, and the incidence of adverse reactions in the two groups were compared. Results: The clinical effective rate of the observation group was higher than that of the control group, and the recurrence rate was lower than that of the control group (P < 0.05); the clinical symptom score of the observation group was lower than that of the control group after treatment (P < 0.05); the water content of the stratum corneum of the observation group was higher than that of the control group after treatment, and the amount of transepidermal water loss was lower than that of the control group (P < 0.05); the incidence of adverse reactions of the two groups did not have any significant difference in comparison (P > 0.05). Conclusion: The treatment effect of intense pulsed light combined with doxycycline in rosacea patients is remarkable. It can alleviate clinical symptoms and improve the skin barrier function, with a lower recurrence rate after treatment and higher therapeutic safety, which is suitable for popularization and use in healthcare institutions.